ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® GU 2024 Insights: "CONTACT-2 Study - Cabozantinib & Atezolizumab in Comparison to Second Novel Hormonal Therapy in Patients With mCRPC"
By
ecancer
FEATURING
Neeraj Agarwal
By
ecancer
FEATURING
Neeraj Agarwal
Login to view comments.
Click here to Login
